Alector (ALEC) Non-Current Debt (2024 - 2026)

Alector (ALEC) posted quarterly Non-Current Debt of $8.3 million for Q1 2026, down 12.44% year-over-year from $9.5 million in Q1 2025, and down 11.11% quarter-over-quarter from $9.3 million in Q4 2025.

Alector (ALEC) Non-Current Debt (2024 - 2026) Analysis & Trends

Alector (ALEC) has reported Non-Current Debt for 3 consecutive years, with $8.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Debt fell 12.44% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (down 12.44% YoY), while the FY2025 annual figure was $9.3 million, down 0.7% from the prior year.
  • Non-Current Debt eased to $8.3 million in Q1 2026 per ALEC's latest filing, from $9.3 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $9.6 million in Q3 2025 and bottomed at $8.3 million in Q1 2026.
  • Historically, Non-Current Debt has averaged $9.3 million across 3 years, with a median of $9.4 million in 2024.
  • Annual changes were most pronounced in 2025 — Non-Current Debt dropped 0.7% — and 2026, when it dropped 12.44%.
  • Alector's Non-Current Debt stood at $9.4 million in 2024, then retreated by 0.7% to $9.3 million in 2025, then decreased by 11.11% to $8.3 million in 2026.
  • Business Quant data shows ALEC's Non-Current Debt at $8.3 million in Q1 2026, $9.3 million in Q4 2025, and $9.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 882.16 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 8.96 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Alector 218.85 Mn 46.05 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 8.29 Mn
Dec 31, 2025 9.32 Mn
Sep 30, 2025 9.61 Mn
Jun 30, 2025 9.54 Mn
Mar 31, 2025 9.46 Mn
Dec 31, 2024 9.39 Mn